1 Min Read
April 9 (Reuters) - Alembic Pharmaceuticals Ltd:
* SAYS CO RECEIVED U.S. FDA APPROVAL FOR ACYCLOVIR OINTMENT USP, 5 PERCENT Source text - bit.ly/2qiUKur Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.